我院自 1999年以来 ,应用低分子肝素钙治疗进展型脑梗死病人 2 3例 ,取得了较为理想的临床效果 ,现分析如下。临床资料 :所有均为住院病人 (有对低分子肝素过敏史或凝血功能障碍等禁忌证者除外 ) ,发病在 6～ 2 4h内 ,神经功能缺失症状呈逐渐进展或呈阶梯式加重 ,诊断为进展性 In our hospital since 1999, the application of low molecular weight heparin calcium in patients with advanced cerebral infarction in 23 cases, and achieved a more satisfactory clinical effect, are analyzed as follows. Clinical data: All were hospitalized patients (with low history of heparin allergy or coagulation disorders and other contraindications, except), the incidence of 6 ~ 2 4h, neurological deficit symptoms progressively progressive or stepped exacerbation, the diagnosis of Progressive